Companies like Moderna did dispense with IP restrictions around the vaccine, but it turns out that this was never a binding constraint in the first place. These vaccines must essentially be brewed via a biological process, not merely synthesized in a chemical lab like most pharmaceuticals. There's probably a whole lot of fuzzy know-how in this that's inherently hard to replicate, no matter what the legal environment is like.